REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Daewoong Pharmaceutical Company Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Daewoong Pharmaceutical Company Indonesia Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Daewoong Pharmaceutical Company Indonesia is an enterprise in Indonesia, with the main office in Central Jakarta. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on December 30, 2005. In its most recent financial highlights, the company reported a net sales revenue increase of 11.99% in 2024. Over the same period, its total assets grew by 11.58%.

Headquarters
UOB Plaza Thamrin Nine Lantai 27 Unit 5
Central Jakarta; Jakarta; Postal Code: 10230

Contact Details: Purchase the Pt Daewoong Pharmaceutical Company Indonesia report to view the information.

Website: http://daewoong.co.id

Basic Information
Registered Capital:
Purchase the Pt Daewoong Pharmaceutical Company Indonesia report to view the information.
Financial Auditors:
Purchase the Pt Daewoong Pharmaceutical Company Indonesia report to view the information.
Incorporation Date:
December 30, 2005
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Daewoong Pharmaceutical Company Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
11.99%
Total Operating Revenue
11.99%
Total Assets
11.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?